Valid QL instruments are available; however, low feasibility in typical treatment settings remains a barrier to QL assessment.
The Lung Cancer Symptom Scale (LCSS) is a validated and extensively used paper measure based on a tested model. The LCSS has been converted into a computerized format for a simple hand-held device (pocket PC).
The electronic LCSS is available in more than 40 languages, making it feasible to collect reliable QL data rapidly in international trials, and for use in most countries. 
2.
To test the feasibility of an interactive QL assessment software program using a hand-held PC instrument, LCSS-QL, to evaluate if this method is appropriate for use in clinical trials and patient management.
To determine the correlation of the LCSS-QL with the paper version. If there is good correlation, then the extensive findings from prior experience with the paper version should apply to the electronic version.
To assess acceptability of the LCSS-QL by patients, nurses, and physicians.
METHODS
This psychometric trial used a methodological design to evaluate the feasibility, reliability, and validity of a computer-generated QL instrument specific to patients with lung cancer -the Lung Cancer Symptom Scale electronic version (LCSS-QL).
All patients have advanced NSCLC, KPS > 60, no prior chemotherapy, and are receiving initial courses of docetaxel + platinum.
Patients are entered in the community settings of 9 COMET Group clinics in Ontario, Canada.
200 patients with non-small cell lung cancer are planned; 63 patients to date.
The initial 80 complete both the paper and electronic forms (pretreatment, and with the next 4 chemotherapy cycles -paper version with every other cycle). The final 120 complete only the LCSS-QL. The original paper VAS form is administered first, followed by the computer version to prevent bias of prior computer experience.
A patient demographic and evaluation form (with time of completion/ease of use) is administered on two occasions to each of the first 80 patients (at baseline -visit 1; and at week 7 -visit 3).
• Patients complete both the patient and observer versions in both paper and electronic formats.
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Lung Cancer Symptom Scale
Strengths from Testing Reliability: Cronbach's alphas were high for the paper (0.84) and electronic (0.88) versions (see Table 3 ). They meet Nunnally and Berstein's (1994) recommended guideline for reliability of greater than 0.70 for new measures and 0.80 for existing measures.
Validity: Means and correlation coefficients between the paper and electronic forms were in near agreement for several correlation methods, including two that reduce measurement bias (see Tables 2  & 3) . Quality of Life evaluation is easier to perform in practice settings or clinical trials, by using a hand-held computer and immediate graphic reports.
Convergence between the two formats is high, and existing psychometric properties for the original measure can be generalized to the new format. There is no bias associated with the hand-held as shown by the equality of the measures of concordance.
The high acceptance rate by patients and professionals, the rapid completion time, and good psychometric properties (feasibility, reliability, and validity) confirm that the electronic LCSS is valid and practical for evaluating QL and PRO endpoints in clinical trials and in patient management.
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